Larry Douglas Altstiel insider trades

Open-market stock purchases and sales by Larry Douglas Altstiel, Chief Medical Officer at ProMIS Neurosciences Inc, from SEC Form 4 filings since Sep 12, 2014.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +64%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • PMN ProMIS Neurosciences Inc: other filings, last Sep 22, 2025
  • VTVT vTv Therapeutics Inc: other filings, last Mar 10, 2017
  • NTRP Neurotrope, Inc: 2 buys, last Nov 19, 2015

Get free alerts when Larry Douglas Altstiel files a new trade →